COLL
Collegium Pharmaceutical, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth +11.8% ·
share flow +3.1% ·
net new positions +10.5%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | +3 | 27.22M | $985.07M | +8 | −7 |
| Q1 2026 | 98 | -1 | 28.14M | $930.88M | +7 | −9 |
| Q4 2025 | 100 | 0 | 26.92M | $1.25B | +1 | n/a |
| Q3 2025 | 19 | +2 | 14.79M | $517.39M | +2 | n/a |
| Q2 2025 | 14 | +1 | 12.36M | $365.37M | +1 | n/a |
| Q1 2025 | 10 | -1 | 5.48M | $163.49M | n/a | −1 |
| Q4 2024 | 11 | -1 | 5.00M | $143.28M | n/a | −1 |
| Q3 2024 | 11 | -1 | 3.77M | $145.78M | n/a | −1 |
| Q2 2024 | 12 | n/a | 3.67M | $118.10M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 5.18M | -3.1% | $181.18M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passive) | 2.23M | -1.0% | $77.90M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Renaissance Technologies ✦ | 1.60M | +5.1% | $55.96M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passive) | 1.29M | -4.5% | $45.27M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 836.38K | +7.2% | $29.27M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Goldman Sachs Group ✦ | 802.23K | n/a | $28.07M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 767.42K | n/a | $26.85M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 8 | JPMorgan Chase ✦ | 423.51K | n/a | $14.82M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 9 | D. E. Shaw & Co. ✦ | 389.77K | +91.1% | $13.64M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Marshall Wace ✦ | 279.01K | +104.1% | $9.76M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 269.32K | +897.2% | $9.42M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 253.50K | +5.6% | $8.87M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | Wellington Management ✦ | 122.98K | +24.3% | $4.30M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 14 | Millennium Management ✦ | 122.19K | -45.5% | $4.28M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 87.18K | -3.5% | $3.05M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 16 | Fidelity (FMR) ✦ | 58.86K | +12.0% | $2.06M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 17 | T. Rowe Price ✦ | 34.97K | -3.6% | $1.22M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 33.71K | New | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 8.19K | New | $286,393 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $1.18M | 0.0% |
| Gotham Asset Management | $286,393 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 264 holders, 37.57M shares, $1.22B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.